35401225|t|Alpha-Asaronol Alleviates Dysmyelination by Enhancing Glutamate Transport Through the Activation of PPARgamma-GLT-1 Signaling in Hypoxia-Ischemia Neonatal Rats.
35401225|a|Preterm white matter injury (PWMI) is the most common form of brain damage in premature infants caused by hypoxia-ischemia (HI), inflammation, or excitotoxicity. It is characterized by oligodendrocyte precursor cell (OPC) differentiation disorder and dysmyelination. Our previous study confirmed that alpha-asarone (alpha-asaronol), a major compound isolated from the Chinese medicinal herb Acorus gramineus by our lab, could alleviate neuronal overexcitation and improve the cognitive function of aged rats. In the present study, we investigated the effect and mechanism of alpha-asaronol on myelination in a rat model of PWMI induced by HI. Notably, alpha-asaronol promoted OPC differentiation and myelination in the corpus callosum of PWMI rats. Meanwhile, the concentration of glutamate was significantly decreased, and the levels of PPARgamma and glutamate transporter 1 (GLT-1) were increased by alpha-asaronol treatment. In vitro, it was also confirmed that alpha-asaronol increased GLT-1 expression and recruitment of the PPARgamma coactivator PCG-1a in astrocytes under oxygen and glucose deprivation (OGD) conditions. The PPARgamma inhibitor GW9662 significantly reversed the effect of alpha-asaronol on GLT-1 expression and PCG-1a recruitment. Interestingly, the conditioned medium from alpha-asaronol-treated astrocytes decreased the number of OPCs and increased the number of mature oligodendrocytes. These results suggest that alpha-asaronol can promote OPC differentiation and relieve dysmyelination by regulating glutamate levels via astrocyte PPARgamma-GLT-1 signaling. Although whether alpha-asaronol binds to PPARgamma directly or indirectly is not investigated here, this study still indicates that alpha-asaronol may be a promising small molecular drug for the treatment of myelin-related diseases.
35401225	0	14	Alpha-Asaronol	Chemical	MESH:C000712277
35401225	26	40	Dysmyelination	Disease	MESH:D003711
35401225	54	63	Glutamate	Chemical	MESH:D018698
35401225	100	109	PPARgamma	Gene	25664
35401225	110	115	GLT-1	Gene	29482
35401225	129	137	Hypoxia-	Disease	MESH:D000860
35401225	137	145	Ischemia	Disease	MESH:D007511
35401225	155	159	Rats	Species	10116
35401225	161	188	Preterm white matter injury	Disease	MESH:D047928
35401225	190	194	PWMI	Disease	MESH:D047928
35401225	223	235	brain damage	Disease	MESH:D001925
35401225	267	274	hypoxia	Disease	MESH:D000860
35401225	275	283	ischemia	Disease	MESH:D007511
35401225	285	287	HI	Disease	MESH:D020925
35401225	290	302	inflammation	Disease	MESH:D007249
35401225	307	321	excitotoxicity	Disease	
35401225	362	371	precursor	Disease	MESH:D054198
35401225	383	398	differentiation	Disease	MESH:D012734
35401225	412	426	dysmyelination	Disease	MESH:D003711
35401225	462	475	alpha-asarone	Chemical	MESH:C012195
35401225	477	491	alpha-asaronol	Chemical	MESH:C000712277
35401225	552	568	Acorus gramineus	Species	55184
35401225	597	620	neuronal overexcitation	Disease	MESH:D009410
35401225	664	668	rats	Species	10116
35401225	736	750	alpha-asaronol	Chemical	MESH:C000712277
35401225	771	774	rat	Species	10116
35401225	784	788	PWMI	Disease	MESH:D047928
35401225	800	802	HI	Disease	MESH:D020925
35401225	813	827	alpha-asaronol	Chemical	MESH:C000712277
35401225	841	856	differentiation	Disease	MESH:D012734
35401225	899	903	PWMI	Disease	MESH:D047928
35401225	904	908	rats	Species	10116
35401225	942	951	glutamate	Chemical	MESH:D018698
35401225	999	1008	PPARgamma	Gene	25664
35401225	1013	1036	glutamate transporter 1	Gene	29482
35401225	1038	1043	GLT-1	Gene	29482
35401225	1063	1077	alpha-asaronol	Chemical	MESH:C000712277
35401225	1126	1140	alpha-asaronol	Chemical	MESH:C000712277
35401225	1151	1156	GLT-1	Gene	29482
35401225	1191	1200	PPARgamma	Gene	25664
35401225	1240	1246	oxygen	Chemical	MESH:D010100
35401225	1251	1258	glucose	Chemical	MESH:D005947
35401225	1293	1302	PPARgamma	Gene	25664
35401225	1313	1319	GW9662	Chemical	MESH:C457499
35401225	1357	1371	alpha-asaronol	Chemical	MESH:C000712277
35401225	1375	1380	GLT-1	Gene	29482
35401225	1459	1473	alpha-asaronol	Chemical	MESH:C000712277
35401225	1602	1616	alpha-asaronol	Chemical	MESH:C000712277
35401225	1633	1648	differentiation	Disease	MESH:D012734
35401225	1661	1675	dysmyelination	Disease	MESH:D003711
35401225	1690	1699	glutamate	Chemical	MESH:D018698
35401225	1721	1730	PPARgamma	Gene	25664
35401225	1731	1736	GLT-1	Gene	29482
35401225	1765	1779	alpha-asaronol	Chemical	MESH:C000712277
35401225	1789	1798	PPARgamma	Gene	25664
35401225	1880	1894	alpha-asaronol	Chemical	MESH:C000712277
35401225	1956	1979	myelin-related diseases	Disease	MESH:D003711
35401225	Negative_Correlation	MESH:C457499	29482
35401225	Association	MESH:D018698	29482
35401225	Positive_Correlation	MESH:C000712277	29482
35401225	Association	MESH:D018698	25664
35401225	Association	MESH:D003711	29482
35401225	Association	25664	29482
35401225	Negative_Correlation	MESH:C457499	25664
35401225	Association	MESH:D018698	MESH:D003711
35401225	Negative_Correlation	MESH:C000712277	MESH:D003711
35401225	Negative_Correlation	MESH:C000712277	MESH:C457499
35401225	Negative_Correlation	MESH:C000712277	MESH:D009410
35401225	Positive_Correlation	MESH:C000712277	MESH:D012734
35401225	Positive_Correlation	MESH:C000712277	25664
35401225	Positive_Correlation	MESH:C000712277	MESH:D018698
35401225	Negative_Correlation	MESH:C012195	MESH:D009410

